Developer docs
API playgroundTry for free, no card

Search company profiles

DoseSpot

Full company profile

uuid0003li5

Namestring
DoseSpot
Legal namestring
PRN Software
Websiteurl
dosespot.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

DoseSpot (legally PRN Software, founded 2009, headquartered in Boston) provides a cloud-based, certified ePrescribing platform that enables healthcare providers to electronically transmit prescriptions—including controlled substances—directly into a nationwide pharmacy routing network. The platform is offered at three integration tiers: Full Integration (250+ API endpoints, fully customizable UI, 3–6 month rollout), Jumpstart (70+ APIs, plug-and-play iFrame embed, ~30 day implementation, adopted by roughly 74% of clients), and the standalone TreatRx product for solo providers without an EHR (24–72 hour setup). The product stack layers a core ePrescribing engine with Real-Time Prescription Benefit (patient-specific out-of-pocket cost and formulary data at point of care), Electronic Prior Authorization (under 4 minute approval decisions through CoverMyMeds), and DoseSpot Connect (SMS-based patient engagement, copay assistance, and pharmacy selection). Acquired modules pVerify (patient eligibility verification across 350+ API clients) and RxLink (medication affordability) extend the platform into revenue cycle and patient-support workflows, and the March 2026 merger with Arrive Health combines the ePrescribing engine with real-time medical and pharmacy benefit data under the new Interra Health entity.

The go-to-market is dual-track: an enterprise field sales motion with “Request a Demo” qualification targeting health systems, EHR/EMR vendors, dental service organizations, telehealth platforms, and digital health companies; paired with an API-first OEM/embedded channel that distributes the platform behind 140+ endpoints into partner products. Customer segments span Telehealth and Digital Health (DialCare, ChatRx, Hims & Hers, Maven), Health Systems (provider access and 340B performance), EHRs/EMRs (Genensys, InPracSys, OpenDental), Provider Groups, and DSOs and dental practices (Henry Schein, Aspen Dental, Smile Brands), with solo providers addressed via TreatRx. Commercial logic is a subscription SaaS model with multi-year enterprise contracts and quote-based pricing; no public tier pricing is disclosed. Strategic ownership moved through PSG’s 2021–2022 growth equity investment, three follow-on acquisitions, and the March 2026 recapitalization by Bain Capital Tech Opportunities as majority owner of Interra Health, with PSG, Providence, and UPMC Enterprises retaining minority positions. The merged entity is described as already profitable with combined revenue projected above $100M in 2026.

Short descriptiontext

DoseSpot is a Boston-based, cloud-based ePrescribing platform offering certified EPCS, real-time prescription benefit, electronic prior authorization, and patient engagement tools to telehealth providers, health systems, EHR/EMR vendors, dental practices, and solo providers across the United States. Since 2026 it operates as Interra Health following a merger with Arrive Health.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
electronic prescribing software, ePrescribing integration, EHR ePrescribing API, controlled substance prescribing, patient medication engagement
Industry5 codes
PRIMARYHLALAIAD
ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLACAKAN
Medication Pricing, Copay Assistance & Patient Financial Support Tools
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLALACAK
Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
SECONDARYHLAEAKAL
PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools)
SECONDARYHLACAKAJ
Controlled Substance ePrescribing (EPCS), Diversion Monitoring & Compliance
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
NAICS code2 codes
  • Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds524292
  • Offices of Physicians62111
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Healthcare E-Prescribing Software
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS ePrescribing Platform Subscription
TypeSubscription Recurring
Description

Subscription-based software-as-a-service model providing ePrescribing capabilities, insurance verification, and patient engagement tools to healthcare providers and organizations.

dosespot.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations
Pricing details1 tier
1Custom enterprise pricing based on organization size and integration requirements
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Quote-based pricing; implementation can be up and running in as little as 30 days; no free trial or freemium model disclosed

dosespot.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1TreatRx
Description

Simple, affordable, and standalone ePrescribing solution for solo providers without an EHR requirement. EPCS-certified to meet federal and state requirements in all 50 states.

dosespot.com
+2 more records
Core offering1 text field

DoseSpot provides a cloud-based, certified electronic prescribing (ePrescribing) platform that enables healthcare providers to electronically send prescriptions, including controlled substances (EPCS), directly to pharmacies. The platform is offered through three integration tiers: Full Integration (250+ APIs, fully custom UI), Jumpstart (70+ APIs, plug-and-play iFrame), and TreatRx (standalone, no EHR required). Additional capabilities include Real-Time Prescription Benefit checks, Electronic Prior Authorization, patient engagement tools, and insurance eligibility verification (via pVerify).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 50M+ prescriptions sent annually
+8 more records
Product overview1 text field

DoseSpot is a certified ePrescribing platform offering a modular product architecture centered on Core ePrescribing as the foundational capability. The platform layers patient-facing tools (DoseSpot Connect with Real-Time Prescription Benefit) and workflow automation (Electronic Prior Authorization) on top of the core ePrescribing engine. Integration is offered at three tiers: Full Integration (250+ APIs, fully custom UI), Jumpstart (70+ APIs, plug-and-play UI), and TreatRx (standalone, no-EHR-required). Following the 2023 acquisitions of TreatRx and pVerify, and the 2024 acquisition of RxLink, DoseSpot merged with Arrive Health in March 2026 to form Interra Health, expanding into real-time medication price transparency and coverage data.

Product and service8 records
1Core ePrescribing
CategoryePrescribing Software
Description

Foundational cloud-based ePrescribing platform providing prescription routing, controlled substance prescribing (EPCS), drug interaction and allergy alerts, PDMP integration, medication history, and customizable Sig configurations for healthcare providers.

2DoseSpot Connect
CategoryPatient Engagement Software
Description

Patient engagement module enabling prescription price transparency, medication affordability programs, co-pay savings, pharmacy choice, and SMS-based prescription communications between providers and patients.

3Real-Time Prescription Benefit (RTPB)
CategoryPrescription Benefit Software
Description

Real-time drug cost visibility and therapeutic alternative suggestions at point of care, integrated into EHR workflows to enable informed prescribing decisions and improve medication adherence.

4Electronic Prior Authorization (ePA)
CategoryPrior Authorization Software
Description

Integrated prior authorization submission, tracking, and decision-making within ePrescribing workflows, connecting to CoverMyMeds and Surescripts for expanded payer coverage.

5Full Integration
CategoryIntegration Platform
Description

Fully customizable cloud-based ePrescribing integration with 250+ API calls, custom screen building, and complete workflow ownership; Surescripts and EPCS certified for enterprise deployments.

6Jumpstart Integration
CategoryIntegration Platform
Description

Plug-and-play ePrescribing user interface (iFrame/embedded) with 70+ API calls, customizable CSS theming, enabling ePrescribing in as little as 30 days for healthcare organizations.

7TreatRx
CategoryStandalone ePrescribing
Description

Standalone ePrescribing platform requiring no EHR/EMR, EPCS-certified for solo providers and small practices, enabling prescribing from any device with real-time prescription benefit and prior authorization capabilities.

8pVerify
CategoryInsurance Verification and RCM
Description

Insurance eligibility verification and revenue cycle management solution serving 350+ API clients via API, SFTP, and HL7/FHIR for medical, dental, and vision providers, pharmacies, labs, developers, health plans, and RCM/billing providers.

Scale indicator20 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
1Arrive Health (Merger)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-01
Description

DoseSpot and Arrive Health merged in March 2026 to form Interra Health. The combination unified ePrescribing platform with medical and pharmacy benefits data to advance real-time medication price transparency.

hitconsultant.net
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

DoseSpot collaborates with Amazon Pharmacy to improve medication availability and price transparency, connecting patients with Amazon's same-day prescription delivery services.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-04-01
Description

Strategic collaboration with Lightning Step to give behavioral health organizations access to DoseSpot's ePrescribing capabilities.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-01-01
Description

DoseSpot acquired RxLink in 2024. RxLink was founded by JB Powell who joined DoseSpot as Head of Growth, Patient Support. RxLink focused on medication affordability solutions.

5CoverMyMeds
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-01-01
Description

CoverMyMeds integration enables electronic prior authorization submission and tracking directly within DoseSpot's ePrescribing workflow, reducing approval rejections and simplifying compliance.

dosespot.com
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-01-01
Description

Surescripts network certification enables DoseSpot to route electronic prescriptions nationwide and access eligibility, formulary, and medication history data.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-01-01
Description

Integration with Pharmacy Benefit Managers provides real-time visibility into out-of-pocket costs, formulary alternatives, and cost-saving opportunities for Real-Time Prescription Benefit features.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-06-01
Description

DoseSpot acquired pVerify in June 2023 to enhance its API capabilities for patient eligibility verification. pVerify provides insurance verification and revenue cycle management solutions.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-03-01
Description

DoseSpot acquired TreatRx, Bravado Health's ePrescribing platform, to expand its solution offerings for healthcare providers. The acquisition enhanced DoseSpot's capabilities and support for practice efficiency and compliance.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

DrFirst is a direct competitor in the ePrescribing space, offering EPCS-certified ePrescribing, medication management, and EHR-integrated prescribing workflows. Both target healthcare providers, EHRs, and digital health platforms with comparable API-first distribution models.

TypeBroad incumbent
Description

Surescripts is the dominant nationwide prescription routing network and also operates adjacent services (benefit, eligibility, prior authorization). While DoseSpot partners with Surescripts, Surescripts also competes in areas like eligibility/benefit and increasingly in decision support, making it both a partner and a partial competitor.

TypeDirect peer
Description

RxNT is an ePrescribing platform offering EPCS-certified ePrescribing, EPCS, and practice management solutions. It targets ambulatory practices and is comparable to DoseSpot's Full Integration and TreatRx standalone offerings.

TypeDirect peer
Description

NewCrop provides cloud-based ePrescribing, EPCS, and medication management integrated into EHR and HIT systems. It is a direct API-first competitor with comparable EPCS-certified workflow capabilities.

5CoverMyMeds (McKesson)
TypeDirect peer
Description

CoverMyMeds is a leading electronic prior authorization platform integrated into DoseSpot's ePA workflow. It is a partner but also a direct competitor in the medication workflow/PA layer of DoseSpot's product, and as part of McKesson it has deep healthcare distribution scale.

TypeBroad incumbent
Description

Veradigm (formerly Allscripts) provides EHR systems with integrated ePrescribing and EPCS. It represents the broad-incumbent threat where an EHR vendor's native ePrescribing reduces the addressable market for best-of-breed solutions like DoseSpot.

TypeBroad incumbent
Description

eClinicalWorks is a major ambulatory EHR vendor offering integrated ePrescribing and EPCS as part of its core suite. It is comparable to DoseSpot as a competitor in the ePrescribing layer for provider practices, particularly for ambulatory and specialty practices.

TypeBroad incumbent
Description

Epic is the dominant EHR for large health systems and offers its own integrated ePrescribing module. While DoseSpot's Jumpstart and Full Integration can work alongside Epic, Epic's native capabilities and tight integration limit DoseSpot's expansion into the largest IDN segment.

TypeBroad incumbent
Description

Practice Fusion, now part of Veradigm, is a cloud-based EHR with integrated ePrescribing targeted at independent practices. It competes with DoseSpot's TreatRx standalone and embedded offerings for the small-practice segment.

TypeEmerging player
Description

Tebra (formed via the merger of Kareo and PatientPop) provides cloud-based practice management and EHR with integrated ePrescribing for independent practices. It overlaps with DoseSpot's TreatRx standalone and Jumpstart offerings for the small-practice and ambulatory segment.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers20 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DoseSpot

Healthcare E-Prescribing Softwaredosespot.com

DoseSpot is a Boston-based, cloud-based ePrescribing platform offering certified EPCS, real-time prescription benefit, electronic prior authorization, and patient engagement tools to telehealth providers, health systems, EHR/EMR vendors, dental practices, and solo providers across the United States. Since 2026 it operates as Interra Health following a merger with Arrive Health.

What DoseSpot does

DoseSpot (legally PRN Software, founded 2009, headquartered in Boston) provides a cloud-based, certified ePrescribing platform that enables healthcare providers to electronically transmit prescriptions—including controlled substances—directly into a nationwide pharmacy routing network. The platform is offered at three integration tiers: Full Integration (250+ API endpoints, fully customizable UI, 3–6 month rollout), Jumpstart (70+ APIs, plug-and-play iFrame embed, ~30 day implementation, adopted by roughly 74% of clients), and the standalone TreatRx product for solo providers without an EHR (24–72 hour setup). The product stack layers a core ePrescribing engine with Real-Time Prescription Benefit (patient-specific out-of-pocket cost and formulary data at point of care), Electronic Prior Authorization (under 4 minute approval decisions through CoverMyMeds), and DoseSpot Connect (SMS-based patient engagement, copay assistance, and pharmacy selection). Acquired modules pVerify (patient eligibility verification across 350+ API clients) and RxLink (medication affordability) extend the platform into revenue cycle and patient-support workflows, and the March 2026 merger with Arrive Health combines the ePrescribing engine with real-time medical and pharmacy benefit data under the new Interra Health entity.

The go-to-market is dual-track: an enterprise field sales motion with “Request a Demo” qualification targeting health systems, EHR/EMR vendors, dental service organizations, telehealth platforms, and digital health companies; paired with an API-first OEM/embedded channel that distributes the platform behind 140+ endpoints into partner products. Customer segments span Telehealth and Digital Health (DialCare, ChatRx, Hims & Hers, Maven), Health Systems (provider access and 340B performance), EHRs/EMRs (Genensys, InPracSys, OpenDental), Provider Groups, and DSOs and dental practices (Henry Schein, Aspen Dental, Smile Brands), with solo providers addressed via TreatRx. Commercial logic is a subscription SaaS model with multi-year enterprise contracts and quote-based pricing; no public tier pricing is disclosed. Strategic ownership moved through PSG’s 2021–2022 growth equity investment, three follow-on acquisitions, and the March 2026 recapitalization by Bain Capital Tech Opportunities as majority owner of Interra Health, with PSG, Providence, and UPMC Enterprises retaining minority positions. The merged entity is described as already profitable with combined revenue projected above $100M in 2026.

DoseSpot firmographics

Firmographics
Name
DoseSpot
Legal name
PRN Software
Website
https://dosespot.com
Company type
Private
Founded year
2009
Operating status
Acquired
Headcount range
51–100 employees
Short description
DoseSpot is a Boston-based, cloud-based ePrescribing platform offering certified EPCS, real-time prescription benefit, electronic prior authorization, and patient engagement tools to telehealth providers, health systems, EHR/EMR vendors, dental practices, and solo providers across the United States. Since 2026 it operates as Interra Health following a merger with Arrive Health.
Ownership category
akta.pro rank

DoseSpot industry classification

Industry
Product category
Healthcare E-Prescribing Software
NAICS
Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Offices of Physicians (62111)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLALAIAD
ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLACAKAN
Medication Pricing, Copay Assistance & Patient Financial Support Tools
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYHLALACAK
Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
SECONDARYHLAEAKAL
PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools)
SECONDARYHLACAKAJ
Controlled Substance ePrescribing (EPCS), Diversion Monitoring & Compliance
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT

Keywords

  • Electronic prescribing software
  • EPrescribing integration
  • EHR ePrescribing API
  • Controlled substance prescribing
  • Patient medication engagement

Where DoseSpot is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Markets served

DoseSpot business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. SaaS ePrescribing Platform Subscription: Subscription-based software-as-a-service model providing ePrescribing capabilities, insurance verification, and patient engagement tools to healthcare providers and organizations.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractCustom enterprise pricing based on organization size and integration requirements

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

DoseSpot product offering

Product offering

Core offering

DoseSpot provides a cloud-based, certified electronic prescribing (ePrescribing) platform that enables healthcare providers to electronically send prescriptions, including controlled substances (EPCS), directly to pharmacies. The platform is offered through three integration tiers: Full Integration (250+ APIs, fully custom UI), Jumpstart (70+ APIs, plug-and-play iFrame), and TreatRx (standalone, no EHR required). Additional capabilities include Real-Time Prescription Benefit checks, Electronic Prior Authorization, patient engagement tools, and insurance eligibility verification (via pVerify).

Product overview

DoseSpot is a certified ePrescribing platform offering a modular product architecture centered on Core ePrescribing as the foundational capability. The platform layers patient-facing tools (DoseSpot Connect with Real-Time Prescription Benefit) and workflow automation (Electronic Prior Authorization) on top of the core ePrescribing engine. Integration is offered at three tiers: Full Integration (250+ APIs, fully custom UI), Jumpstart (70+ APIs, plug-and-play UI), and TreatRx (standalone, no-EHR-required). Following the 2023 acquisitions of TreatRx and pVerify, and the 2024 acquisition of RxLink, DoseSpot merged with Arrive Health in March 2026 to form Interra Health, expanding into real-time medication price transparency and coverage data.

Differentiator

Problem solved

Functional benefit

Brands

  • TreatRx: Simple, affordable, and standalone ePrescribing solution for solo providers without an EHR requirement. EPCS-certified to meet federal and state requirements in all 50 states.
  • pVerify
  • RxLink

Products and services

  • Core ePrescribing Foundational cloud-based ePrescribing platform providing prescription routing, controlled substance prescribing (EPCS), drug interaction and allergy alerts, PDMP integration, medication history, and customizable Sig configurations for healthcare providers.
  • DoseSpot Connect Patient engagement module enabling prescription price transparency, medication affordability programs, co-pay savings, pharmacy choice, and SMS-based prescription communications between providers and patients.
  • Real-Time Prescription Benefit (RTPB) Real-time drug cost visibility and therapeutic alternative suggestions at point of care, integrated into EHR workflows to enable informed prescribing decisions and improve medication adherence.
  • Electronic Prior Authorization (ePA) Integrated prior authorization submission, tracking, and decision-making within ePrescribing workflows, connecting to CoverMyMeds and Surescripts for expanded payer coverage.
  • Full Integration Fully customizable cloud-based ePrescribing integration with 250+ API calls, custom screen building, and complete workflow ownership; Surescripts and EPCS certified for enterprise deployments.
  • Jumpstart Integration Plug-and-play ePrescribing user interface (iFrame/embedded) with 70+ API calls, customizable CSS theming, enabling ePrescribing in as little as 30 days for healthcare organizations.
  • TreatRx Standalone ePrescribing platform requiring no EHR/EMR, EPCS-certified for solo providers and small practices, enabling prescribing from any device with real-time prescription benefit and prior authorization capabilities.
  • pVerify Insurance eligibility verification and revenue cycle management solution serving 350+ API clients via API, SFTP, and HL7/FHIR for medical, dental, and vision providers, pharmacies, labs, developers, health plans, and RCM/billing providers.

Quantifiable outcome

  • 50M+ prescriptions sent annually
  • +8 more outcomes

Companies that use DoseSpot

Customer profile

Named customers20 records

Segments6 records

Ideal customer profiles5 records

DoseSpot technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability3 records

Feature9 records

DoseSpot partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • Arrive Health (Merger)coreStrategic or Co-development Partner · 1 March 2026DoseSpot and Arrive Health merged in March 2026 to form Interra Health. The combination unified ePrescribing platform with medical and pharmacy benefits data to advance real-time medication price transparency.
  • Amazon PharmacyminorStrategic or Co-development Partner · 1 January 2026DoseSpot collaborates with Amazon Pharmacy to improve medication availability and price transparency, connecting patients with Amazon's same-day prescription delivery services.
  • Lightning StepminorStrategic or Co-development Partner · 1 April 2025Strategic collaboration with Lightning Step to give behavioral health organizations access to DoseSpot's ePrescribing capabilities.
  • RxLink (Acquisition)coreTechnology or Integration · 1 January 2024DoseSpot acquired RxLink in 2024. RxLink was founded by JB Powell who joined DoseSpot as Head of Growth, Patient Support. RxLink focused on medication affordability solutions.
  • CoverMyMedscoreTechnology or Integration · 1 January 2024CoverMyMeds integration enables electronic prior authorization submission and tracking directly within DoseSpot's ePrescribing workflow, reducing approval rejections and simplifying compliance.
  • SurescriptscoreTechnology or Integration · 1 January 2024Surescripts network certification enables DoseSpot to route electronic prescriptions nationwide and access eligibility, formulary, and medication history data.
  • Pharmacy Benefit Managers (PBMs)coreTechnology or Integration · 1 January 2024Integration with Pharmacy Benefit Managers provides real-time visibility into out-of-pocket costs, formulary alternatives, and cost-saving opportunities for Real-Time Prescription Benefit features.
  • pVerify (Acquisition)coreTechnology or Integration · 1 June 2023DoseSpot acquired pVerify in June 2023 to enhance its API capabilities for patient eligibility verification. pVerify provides insurance verification and revenue cycle management solutions.
  • Bravado Health (TreatRx acquisition)coreTechnology or Integration · 1 March 2023DoseSpot acquired TreatRx, Bravado Health's ePrescribing platform, to expand its solution offerings for healthcare providers. The acquisition enhanced DoseSpot's capabilities and support for practice efficiency and compliance.

Scale indicators20 records

Recent moves7 records

Expansion highlights6 records

DoseSpot competitors and assessment

Company assessment

Direct peers

  • DrFirst: DrFirst is a direct competitor in the ePrescribing space, offering EPCS-certified ePrescribing, medication management, and EHR-integrated prescribing workflows. Both target healthcare providers, EHRs, and digital health platforms with comparable API-first distribution models.
  • RxNT: RxNT is an ePrescribing platform offering EPCS-certified ePrescribing, EPCS, and practice management solutions. It targets ambulatory practices and is comparable to DoseSpot's Full Integration and TreatRx standalone offerings.
  • NewCrop: NewCrop provides cloud-based ePrescribing, EPCS, and medication management integrated into EHR and HIT systems. It is a direct API-first competitor with comparable EPCS-certified workflow capabilities.
  • CoverMyMeds (McKesson): CoverMyMeds is a leading electronic prior authorization platform integrated into DoseSpot's ePA workflow. It is a partner but also a direct competitor in the medication workflow/PA layer of DoseSpot's product, and as part of McKesson it has deep healthcare distribution scale.

Broad incumbents

  • Surescripts: Surescripts is the dominant nationwide prescription routing network and also operates adjacent services (benefit, eligibility, prior authorization). While DoseSpot partners with Surescripts, Surescripts also competes in areas like eligibility/benefit and increasingly in decision support, making it both a partner and a partial competitor.
  • Veradigm (Allscripts): Veradigm (formerly Allscripts) provides EHR systems with integrated ePrescribing and EPCS. It represents the broad-incumbent threat where an EHR vendor's native ePrescribing reduces the addressable market for best-of-breed solutions like DoseSpot.
  • eClinicalWorks: eClinicalWorks is a major ambulatory EHR vendor offering integrated ePrescribing and EPCS as part of its core suite. It is comparable to DoseSpot as a competitor in the ePrescribing layer for provider practices, particularly for ambulatory and specialty practices.
  • Epic Systems: Epic is the dominant EHR for large health systems and offers its own integrated ePrescribing module. While DoseSpot's Jumpstart and Full Integration can work alongside Epic, Epic's native capabilities and tight integration limit DoseSpot's expansion into the largest IDN segment.
  • Practice Fusion (Veradigm): Practice Fusion, now part of Veradigm, is a cloud-based EHR with integrated ePrescribing targeted at independent practices. It competes with DoseSpot's TreatRx standalone and embedded offerings for the small-practice segment.

Emerging players

  • Kareo (Tebra): Tebra (formed via the merger of Kareo and PatientPop) provides cloud-based practice management and EHR with integrated ePrescribing for independent practices. It overlaps with DoseSpot's TreatRx standalone and Jumpstart offerings for the small-practice and ambulatory segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

DoseSpot social profiles

Digital presence

DoseSpot compliance and trust

Trust signal

Compliance8 records

DoseSpot financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DoseSpot leadership team

Management profile

Number of profiles

Profiles7 records

DoseSpot subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

DoseSpot funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DoseSpot M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DoseSpot

What does DoseSpot do?

DoseSpot provides a cloud-based, certified electronic prescribing (ePrescribing) platform that enables healthcare providers to electronically send prescriptions, including controlled substances (EPCS), directly to pharmacies. The platform is offered through three integration tiers: Full Integration (250+ APIs, fully custom UI), Jumpstart (70+ APIs, plug-and-play iFrame), and TreatRx (standalone, no EHR required). Additional capabilities include Real-Time Prescription Benefit checks, Electronic Prior Authorization, patient engagement tools, and insurance eligibility verification (via pVerify).

Is DoseSpot a public or private company?

DoseSpot is a private company. It is classified as private equity controlled and is currently acquired.

When was DoseSpot founded?

DoseSpot was founded in 2009. It employs 51 to 100 people.

Where is DoseSpot based?

DoseSpot is headquartered in Boston, United States, in the North America region.

How does DoseSpot make money?

One revenue line is on record: saaS ePrescribing Platform Subscription.

Who are DoseSpot's main competitors?

Direct peers on record are DrFirst, RxNT, NewCrop and CoverMyMeds (McKesson). Broad incumbents are Surescripts, Veradigm (Allscripts), eClinicalWorks, Epic Systems and Practice Fusion (Veradigm). Kareo (Tebra) is listed as an emerging player.

Does DoseSpot have an API?

Yes. DoseSpot offers 140+ API endpoints for ePrescribing integration, including Full Integration with 250+ API calls and Jumpstart with 70+ API calls. APIs enable sending and retrieving demographics, medications, allergies, and more. The platform provides push notifications for prescription-specific information and actionable items. API v2 is transitioning to Medi-Span Drug Database. Developer documentation is at go.dosespot.com/jumpstart-partnership_overview.

What industry is DoseSpot in?

DoseSpot's product category is Healthcare E-Prescribing Software. Its primary akta.pro industry code is HLALAIAD, ePrescribing & Medication Workflow Platforms (EPCS, formulary, prior auth, med history), with a secondary code of HLACAKAN, Medication Pricing, Copay Assistance & Patient Financial Support Tools. Its NAICS code is 524292 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PsgequityBuilding a Scaled Clinical Workflow PlatformPSG invested in DoseSpot in 2021 to scale the company's cloud-based ePrescribing platform into a broader clinical workflow solution, executing a three-pronged strategy focused on go-to-market expansion, leadership development, and targeted M&A. Under PSG's ownership, DoseSpot completed three acquisitions (TreatRx, pVerify, and RxLink) to expand capabilities in insurance eligibility verification and medication affordability, ultimately merging with Arrive Health in 2026 to form Interra Health. PSG sold a portion of its stake to Bain Capital Tech Opportunities as part of the new entity formation while retaining a minority position.GlobeNewswireInterra Health, created through the merger of DoseSpot and Arrive Health, ushers in a new era of transparency for patients and providersInterra Health was formed by merging DoseSpot and Arrive Health, delivering real-time coverage, pricing, and pharmacy information to providers and patients. Bain Capital Tech Opportunities leads the investment and will be the majority owner, with PSG and others as minority investors. The company aims to support approximately 800,000 prescribers.HIT ConsultantDoseSpot and Arrive Health Merge to Form Interra HealthHealthcare tech companies DoseSpot and Arrive Health have officially merged to form Interra Health, backed by Bain Capital Tech Opportunities as majority owner along with PSG, Providence, and UPMC Enterprises as minority stakeholders. The combined entity is already profitable, growing at approximately 40% annually and projected to exceed $100 million in revenue in 2026, serving roughly 800,000 prescribers. Interra Health's mission is to address medication affordability by embedding real-time pricing, coverage, and pharmacy alternative data directly into electronic prescribing workflows.FierceHealthcareDoseSpot, Arrive Health merge to combine prescribing tools with pharmacy, medical benefit dataHealthcare technology companies DoseSpot and Arrive Health merged to form Interra Health, backed by Bain Capital Tech Opportunities, to enhance real-time medication price transparency and improve prescribing decisions. The new company integrates Arrive Health's coverage network with DoseSpot's e-prescribing tools, serving around 800,000 providers and projecting over $100 million revenue by 2026.GlobeNewswireDoseSpot's pVerify Achieves Multiple 2025 Recognitions from Gartner Digital Markets' Capterra, Software Advice and GetAppDoseSpot's pVerify solution received 2025 recognitions from Capterra, Software Advice, and GetApp, all part of Gartner Digital Markets. The SaaS platform streamlines insurance verification and revenue cycle management for healthcare providers. DoseSpot plans to continue evolving pVerify to meet changing customer needs.Business InsiderDoseSpot's pVerify Achieves Multiple 2025 Recognitions from Gartner Digital Markets' Capterra, Software Advice and GetAppDoseSpot announced that its pVerify solution received multiple 2025 recognitions from Capterra, Software Advice, and GetApp—all platforms under Gartner Digital Markets—specifically in the Medical Billing category. pVerify is a SaaS platform specializing in patient healthcare insurance eligibility and benefits verification, offering API access, SFTP batch processing, and revenue cycle management tools. CEO Josh Weiner stated that these recognitions demonstrate the consistent value pVerify delivers to users, with the company committed to evolving and enhancing the solution going forward.GlobeNewswireDoseSpot Collaborates with Amazon Pharmacy to Improve Prescription Medication Pricing Transparency, Give Patients More Fulfillment OptionsDoseSpot announced a collaboration with Amazon Pharmacy to improve prescription pricing transparency and offer home delivery options. The partnership aims to address barriers like cost and availability, citing a survey where 33% of Americans don't fill prescriptions due to cost. DoseSpot's software provides real-time pharmacy and inventory visibility.GlobeNewswireDoseSpot Ends Sticker Shock at the Pharmacy with Launch of New ePrescribing Solution that Gives Patients Best Pricing and Pharmacy ChoiceDoseSpot launched DoseSpot Connect, an all-in-one ePrescribing solution that gives patients pharmacy choice and cost-saving options. The suite includes SMS copay assistance, pharmacy selection with pricing visibility, and a new provider interface. The company will debut the product at ViVE 2025.GlobeNewswireDoseSpot Ends Sticker Shock at the Pharmacy with Launch of New ePrescribing Solution that Gives Patients Best Pricing and Pharmacy ChoiceDoseSpot launched DoseSpot Connect, an ePrescribing suite giving patients pharmacy choice and price transparency. The solution integrates with electronic prescription networks and includes copay assistance and pharmacy selection. It will debut at ViVE 2025.GlobeNewswireDoseSpot Improves Pricing Visibility for Dental Patients with Automated Insurance Eligibility and Benefits Software for Dental PracticesDoseSpot launched pVerify for Dental, software that verifies dental patients' insurance eligibility and benefits. It integrates with 1,500+ payers and provides customized eligibility results, allowing providers to discuss treatment options in the moment.